Dopamine D2 agonist priming in intact and dopamine-lesioned rats

被引:0
|
作者
Richard M. Kostrzewa
John P. Kostrzewa
Przemyslaw Nowak
Rose Anna Kostrzewa
Ryszard Brus
机构
[1] East Tennessee State University,Department of Pharmacology, Quillen College of Medicine
[2] Medical University of Silesia,Department of Pharmacology
来源
Neurotoxicity Research | 2004年 / 6卷
关键词
Dopamine; Receptor supersensitivity; Priming; D; receptors; Motor Dyskinesia;
D O I
暂无
中图分类号
学科分类号
摘要
Receptor priming is a recently discovered phenomenon by which receptor agonists produce abrupt and long-lived supersensitization of receptors. Induction of dopamine (DA) D2 receptor supersensitivity by the agonist quinpirole was discovered approximately 15 years ago, and was found to occur consistently if rats were treated repeatedly at daily or weekly or monthly intervals with low or high doses of quinpirole. In this review we summarize and discuss some of the major studies that underlie DA D2 receptor supersen-sitivity, describe behavioral processes that are known to be altered by DA D2 receptor supersensitivity, and discuss the importance of DA innervation on expression of enhanced behaviors. DA D2 receptor supersen-sitivity represents one of the neural mechanisms implicated in psychiatric disorders. Also, DA D2 receptor supersensitivity and increased DA D3 receptor expression are associated with motor dyskinesias, as in L-DOPA-treated Parkinson’s disease patients. An understanding of receptor priming, a knowledge of the types of behavioral expression associated with DA D2 receptor supersensitivity, and an understanding of mechanisms associated with receptor supersen-sitization, can lead to improvements in the treatments of psychiatric and neurological disorders.
引用
收藏
页码:457 / 462
页数:5
相关论文
共 50 条
  • [1] Dopamine D2 agonist priming in intact and dopamine-lesioned rats
    Kostrzewa, RM
    Kostrzewa, JP
    Nowak, P
    Kostrzewa, RA
    Brus, R
    [J]. NEUROTOXICITY RESEARCH, 2004, 6 (06) : 457 - 462
  • [2] HYPERACTIVITY IN NEONATALLY DOPAMINE-LESIONED RATS REQUIRES RESIDUAL ACTIVITY IN MESOLIMBIC DOPAMINE NEURONS
    LUTHMAN, J
    LINDQVIST, E
    OGREN, SO
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 51 (01) : 159 - 163
  • [3] Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats
    Drake, Jonathan D.
    Kibuuka, Laura N.
    Dimitrov, Kroum D.
    Pollack, Alexia E.
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2013, 105 : 26 - 33
  • [4] TERGURIDE, A DOPAMINE D2 PARTIAL AGONIST, AS A DISCRIMINATIVE STIMULUS IN RATS
    YAMAGUCHI, M
    KIMURAIWASAKI, K
    AKAI, T
    NAKADA, Y
    NAKAGAWA, H
    [J]. BEHAVIOURAL PHARMACOLOGY, 1991, 2 (03): : 233 - 240
  • [5] The Effects of the Dopamine D2 Agonist Sumanirole on Prepulse Inhibition in Rats
    Weber, Martin
    Chang, Wei-li
    Breier, Michelle R.
    Yang, Alex C.
    Lee, Kyounghee
    Millan, Mark J.
    Swerdlow, Neal R.
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 73S - 73S
  • [6] The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats
    Weber, Martin
    Chang, Wei-Li
    Breier, Michelle R.
    Yang, Alex
    Millan, Mark J.
    Swerdlow, Neal R.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 (06) : 421 - 425
  • [7] Effects of the dopamine D2 agonist, quinpirole, on time and number processing in rats
    Santi, A
    Coppa, R
    Ross, L
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 68 (01) : 147 - 155
  • [8] Involvement of dopamine D1 and D2 receptors in Fos immunoreactivity induced by stepholidine in both intact and denervated striatum of lesioned rats
    Guo, X
    Ding, YM
    Hu, JY
    Jin, GZ
    [J]. LIFE SCIENCES, 1998, 62 (25) : 2295 - 2302
  • [9] Development of a Bivalent Dopamine D2 Receptor Agonist
    Kuehhorn, Julia
    Goetz, Angela
    Huebner, Harald
    Thompson, Dawn
    Whistler, Jennifer
    Gmeiner, Peter
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (22) : 7911 - 7919
  • [10] Clozapine: partial agonist at dopamine D2 receptors!
    I. Ninan
    S. K. Kulkarni
    [J]. Psychopharmacology, 1998, 138 : 215 - 216